ID: ALA4293322

Max Phase: Preclinical

Molecular Formula: C12H14N4O2S

Molecular Weight: 278.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)NC1=NN(C(C)=O)C(C)(c2ccncc2)S1

Standard InChI:  InChI=1S/C12H14N4O2S/c1-8(17)14-11-15-16(9(2)18)12(3,19-11)10-4-6-13-7-5-10/h4-7H,1-3H3,(H,14,15,17)

Standard InChI Key:  YSVMCOKTUYMRHA-UHFFFAOYSA-N

Associated Targets(Human)

Kinesin-like protein 1 1720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 278.34Molecular Weight (Monoisotopic): 278.0837AlogP: 1.26#Rotatable Bonds: 1
Polar Surface Area: 74.66Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.68CX Basic pKa: 4.98CX LogP: 0.58CX LogD: 0.58
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.84Np Likeness Score: -0.68

References

1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F..  (2018)  Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors.,  156  [PMID:30031975] [10.1016/j.ejmech.2018.07.006]

Source